Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 23 Aug 2024 | 23 Aug 2024 |
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Resignation of Company Secretary & Compliance Officer | ||
Board Meeting | 12 Aug 2024 | 5 Aug 2024 |
RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Un-Audited Standalone Financial Results for the quarter ended June 30 2024 | ||
Board Meeting | 24 May 2024 | 13 May 2024 |
RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve Audited Standalone Financial Results as per Regulation 33 of SEBI (LODR) Regulations 2015 for the quarter and year ended March 31 2024 Approval of Audited Standalone Financial Results for the quarter and year ended March 31, 2024 Outcome of Board Meeting Dated 24/05/2024 (As Per BSE Announcement Dated on 24/05/2024) | ||
Board Meeting | 17 Apr 2024 | 17 Apr 2024 |
Outcome of Board Meeting pursuant to under Regulation 30 of SEBI (LODR) Regulations, 2015- change in Registered office of the Company within Local Limits | ||
Board Meeting | 6 Feb 2024 | 25 Jan 2024 |
RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve Unaudited Standalone Financial Results for the Quarter ended 31st December 2023. Approval of Unaudited Stanalone Financial Result for the Quarter ended 31st December 2023 of Raymed Labs Limited (As Per BSE Announcement Dated on: 06/02/2024) Intimation under Regulation 30 of SEBI LODR Regulation , 2015 -Newspaper Publication (As Per BSE Announcement Dated on 07/02/2024) | ||
Board Meeting | 15 Dec 2023 | 15 Dec 2023 |
Intimation under Regulation 30(5) of SEBI LODR Regulations 2015-Authorisation & Contact details of Key Managerial Personnel of the Company | ||
Board Meeting | 4 Nov 2023 | 27 Oct 2023 |
RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 inter alia to consider and approve Unaudited Standalone Financial Results as per Regulation 33 of SEBI (LODR) Regulations 2015 for quarter and half year ended September 30 2023 together with the Limited Review Report. Un-audited Standalone Financial Results for the quarter and half year ended September 30, 2023 Outcome of Board Meeting for approval of Un-audited Financial Results for the Quarter and Half Year ended September 30, 2023 Outcome of Board Meeting dated 04/11/2023 (As Per BSE Announcement Dated on 04/11/2023) |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice